Straumann Holding AG (OTCMKTS:SAUHY) Short Interest Up 334.8% in January

Straumann Holding AG (OTCMKTS:SAUHY) was the target of a significant increase in short interest during the month of January. As of January 15th, there was short interest totaling 58,271 shares, an increase of 334.8% from the December 31st total of 13,401 shares. Based on an average daily volume of 121,542 shares, the days-to-cover ratio is presently 0.5 days. Based on an average daily volume of 121,542 shares, the days-to-cover ratio is presently 0.5 days.

Analyst Ratings Changes

Several analysts have issued reports on SAUHY shares. Morgan Stanley reaffirmed an “underweight” rating on shares of Straumann in a research report on Monday, December 15th. The Goldman Sachs Group downgraded Straumann from a “strong-buy” rating to a “neutral” rating in a research report on Monday, October 13th. UBS Group upgraded shares of Straumann from a “sell” rating to a “neutral” rating in a report on Tuesday, November 4th. Deutsche Bank Aktiengesellschaft raised shares of Straumann from a “hold” rating to a “buy” rating in a research report on Friday, October 31st. Finally, Citigroup reaffirmed a “sell” rating on shares of Straumann in a research report on Wednesday, January 14th. One research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, two have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold”.

Straumann Stock Performance

SAUHY opened at $11.95 on Friday. The firm’s 50-day moving average price is $11.95 and its 200-day moving average price is $11.91. Straumann has a 52-week low of $10.30 and a 52-week high of $15.00.

Straumann Company Profile

Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.

In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.